Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Effectiveness of tobacco cessation interventions for different groups of tobacco users in Sweden : a study protocol for a national prospective cohort study

Rasmussen, Mette LU orcid ; Larsson, Matz LU ; Gilljam, Hans ; Adami, Johanna ; Wärjerstam, Sanne ; Post, Ann ; Björk-Eriksson, Thomas ; Helgason, Asgeir R and Tønnesen, Hanne LU (2022) In BMJ Open 12(1). p.1-7
Abstract

INTRODUCTION: Tobacco is still one of the single most important risk factors among the lifestyle habits that cause morbidity and mortality in humans. Furthermore, tobacco has a heavy social gradient, as the consequences are even worse among disadvantaged and vulnerable groups. To reduce tobacco-related inequity in health, those most in need should be offered the most effective tobacco cessation intervention. The aim of this study is to facilitate and improve the evaluation of already implemented national tobacco cessation efforts, focusing on 10 disadvantaged and vulnerable groups of tobacco users.

METHODS AND ANALYSIS: This is a prospective cohort study. Data will be collected by established tobacco cessation counsellors in... (More)

INTRODUCTION: Tobacco is still one of the single most important risk factors among the lifestyle habits that cause morbidity and mortality in humans. Furthermore, tobacco has a heavy social gradient, as the consequences are even worse among disadvantaged and vulnerable groups. To reduce tobacco-related inequity in health, those most in need should be offered the most effective tobacco cessation intervention. The aim of this study is to facilitate and improve the evaluation of already implemented national tobacco cessation efforts, focusing on 10 disadvantaged and vulnerable groups of tobacco users.

METHODS AND ANALYSIS: This is a prospective cohort study. Data will be collected by established tobacco cessation counsellors in Sweden. The study includes adult tobacco or e-cigarette users, including disadvantaged and vulnerable patients, receiving in-person interventions for tobacco or e-cigarette cessation (smoking, snus and/or e-cigarettes). Patient inclusion was initiated in April 2020. For data analyses patients will be sorted into vulnerable groups based on risk factors and compared with tobacco users without the risk factor in question.The primary outcome is continuous successful quitting after 6 months, measured by self-reporting. Secondary outcomes include abstinence at the end of the treatment programme, which could be from minutes over days to weeks, 14-day point prevalence after 6 months, and patient satisfaction with the intervention. Effectiveness of successful quitting will be examined by comparing vulnerable with non-vulnerable patients using a mixed-effect logistic regression model adjusting for potential prognostic factors and known confounders.

ETHICS AND DISSEMINATION: The project will follow the guidelines from the Swedish Data Protection Authority and have been approved by the Swedish Ethical Review Authority before patient inclusion (Dnr: 2019-02221). Only patients providing written informed consent will be included. Both positive and negative results will be published in scientific peer-reviewed journals and presented at national and international conferences. Information will be provided through media available to the public, politicians, healthcare providers and planners as these are all important stakeholders.

TRIAL REGISTRATION NUMBER: NCT04819152.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
BMJ Open
volume
12
issue
1
article number
e053090
pages
1 - 7
publisher
BMJ Publishing Group
external identifiers
  • scopus:85123816550
  • pmid:35078840
ISSN
2044-6055
DOI
10.1136/bmjopen-2021-053090
project
National project on the effectiveness of tobacco interventions
language
English
LU publication?
yes
additional info
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
id
c815fed8-fcfb-491c-bede-7734f5929686
date added to LUP
2022-01-27 09:39:05
date last changed
2024-04-25 17:10:26
@article{c815fed8-fcfb-491c-bede-7734f5929686,
  abstract     = {{<p>INTRODUCTION: Tobacco is still one of the single most important risk factors among the lifestyle habits that cause morbidity and mortality in humans. Furthermore, tobacco has a heavy social gradient, as the consequences are even worse among disadvantaged and vulnerable groups. To reduce tobacco-related inequity in health, those most in need should be offered the most effective tobacco cessation intervention. The aim of this study is to facilitate and improve the evaluation of already implemented national tobacco cessation efforts, focusing on 10 disadvantaged and vulnerable groups of tobacco users.</p><p>METHODS AND ANALYSIS: This is a prospective cohort study. Data will be collected by established tobacco cessation counsellors in Sweden. The study includes adult tobacco or e-cigarette users, including disadvantaged and vulnerable patients, receiving in-person interventions for tobacco or e-cigarette cessation (smoking, snus and/or e-cigarettes). Patient inclusion was initiated in April 2020. For data analyses patients will be sorted into vulnerable groups based on risk factors and compared with tobacco users without the risk factor in question.The primary outcome is continuous successful quitting after 6 months, measured by self-reporting. Secondary outcomes include abstinence at the end of the treatment programme, which could be from minutes over days to weeks, 14-day point prevalence after 6 months, and patient satisfaction with the intervention. Effectiveness of successful quitting will be examined by comparing vulnerable with non-vulnerable patients using a mixed-effect logistic regression model adjusting for potential prognostic factors and known confounders.</p><p>ETHICS AND DISSEMINATION: The project will follow the guidelines from the Swedish Data Protection Authority and have been approved by the Swedish Ethical Review Authority before patient inclusion (Dnr: 2019-02221). Only patients providing written informed consent will be included. Both positive and negative results will be published in scientific peer-reviewed journals and presented at national and international conferences. Information will be provided through media available to the public, politicians, healthcare providers and planners as these are all important stakeholders.</p><p>TRIAL REGISTRATION NUMBER: NCT04819152.</p>}},
  author       = {{Rasmussen, Mette and Larsson, Matz and Gilljam, Hans and Adami, Johanna and Wärjerstam, Sanne and Post, Ann and Björk-Eriksson, Thomas and Helgason, Asgeir R and Tønnesen, Hanne}},
  issn         = {{2044-6055}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{1}},
  pages        = {{1--7}},
  publisher    = {{BMJ Publishing Group}},
  series       = {{BMJ Open}},
  title        = {{Effectiveness of tobacco cessation interventions for different groups of tobacco users in Sweden : a study protocol for a national prospective cohort study}},
  url          = {{http://dx.doi.org/10.1136/bmjopen-2021-053090}},
  doi          = {{10.1136/bmjopen-2021-053090}},
  volume       = {{12}},
  year         = {{2022}},
}